Affordable Access

Itraconazole versus griseofulvine in the treatment of tinea corporis and tinea cruris.

Authors
Type
Published Article
Journal
Indian Journal of Dermatology Venereology and Leprology
0378-6323
Publisher
Medknow Publications
Publication Date
Volume
61
Issue
4
Pages
209–211
Identifiers
PMID: 20952956
Source
Medline

Abstract

126 patients (82 males and 44 females) aged above 12 years, suffering from tinea corporis and/or tinea cruris, were treated with either itraconazole (100 mg once a day for 2 weeks and then plecebo for 2 weeks) (63 patients), or griseofulvin (250 mg twice a day for 4 weeks). 90.47% of the patients treated with itraconzole improved whereas griseofulvin imporved 76.19% of patients, clinically. Mycological response was 72% with itraconazole and 57% with griseofulvin.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments